Nizatidine (CAS 76963-41-2): Properties, Applications, and Market Insights
Explore the essential details of Nizatidine, a key player in gastrointestinal health and pharmaceutical research.
Get a Quote & SampleProduct Core Value
Nizatidine
Nizatidine is a potent, selective, competitive, and fully reversible histamine H2-receptor antagonist, significantly reducing gastric acid and pepsin secretion. It is widely used for the treatment of duodenal ulcers, benign gastric ulcers, prevention of ulcer recurrence, and gastroesophageal reflux disease (GERD). Its favorable pharmacokinetic profile and limited drug interactions make it a valuable option in treating acid-related disorders.
- Understanding nizatidine therapeutic indications is crucial for effective patient treatment of conditions like duodenal ulcers.
- The recommended nizatidine posology and method of administration ensures optimal therapeutic outcomes.
- Exploring nizatidine interaction with other medicinal products helps in safe concurrent medication.
- The nizatidine pharmacokinetic properties demonstrate its efficient absorption and elimination pathways.
Key Advantages
Effective Acid Suppression
Nizatidine's mechanism of action as an H2-receptor antagonist provides reliable control over gastric acid secretion, aiding in ulcer healing and symptom relief for acid reflux sufferers.
Favorable Safety Profile
The drug exhibits limited interaction with other medicinal products, contributing to its safe use in patients with various co-morbidities, as supported by nizatidine pharmacodynamic properties.
Versatile Therapeutic Use
From treating active ulcers to preventing their recurrence and managing GERD, nizatidine's broad range of nizatidine therapeutic indications offers comprehensive patient care.
Key Applications
Ulcer Treatment
Nizatidine is a primary treatment for duodenal and benign gastric ulcers, accelerating healing and reducing pain by effectively managing gastric acid levels.
GERD Management
For gastroesophageal reflux disease, nizatidine helps alleviate heartburn and heal associated erosions and ulcerations, improving patients' quality of life.
Ulcer Prevention
Prophylactic maintenance therapy with nizatidine is used to prevent the recurrence of duodenal or benign gastric ulcers, particularly in high-risk individuals.
Pharmaceutical Research
As a well-characterized compound, Nizatidine (CAS 76963-41-2) serves as a vital pharmaceutical intermediate and reference standard in drug development and quality control.